Home/Filings/4/0000899243-22-024711
4//SEC Filing

Sachs Jessica 4

Accession 0000899243-22-024711

CIK 0001622229other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 9:19 AM ET

Size

5.0 KB

Accession

0000899243-22-024711

Insider Transaction Report

Form 4
Period: 2022-06-30
Sachs Jessica
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2022-06-30$7.39/sh+622$4,600622 total
Footnotes (1)
  • [F1]The shares were acquired under the Cogent Biosciences, Inc. 2018 Employee Stock Purchase Plan. The transaction is exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Issuer

Cogent Biosciences, Inc.

CIK 0001622229

Entity typeother

Related Parties

1
  • filerCIK 0001782545

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 9:19 AM ET
Size
5.0 KB